Key Statistics
Market Cap$434.55M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.00
52W High$7.73
52W Low$2.87
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees57
Price Performance
1 Week+10.60%
3 Month-18.34%
1 Year-25.11%
FinancialsAnnual · QuiverQuant
Revenue$426,000
Assets$210.64M
Liabilities$16.54M
Net Income$88.45M loss
About
Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ALT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.